We, TOHO HOLDINGS CO., LTD. and its group companies, conduct pharmaceutical wholesaling, dispensing pharmacy, pharmaceutical manufacturing and sales, and other businesses as a corporate group engaged in the medical, health-care, and nursing care industries. Since our founding, we have been endeavoring to create social value through medical and health-care services.

 

The Group developed the Medium-term Management Plan 2023-2025 “Create the Next Generation,” for a period of three years from 2023. It set out four basic policies: (1) Business transformation, (2) Investment for growth and improvement of profitability, (3) Sustainability management, and (4) Improvement of capital efficiency and enhancement of shareholder returns. Based on these policies, we implemented specific measures to maintain sustainable growth and enhance corporate value through such means as active business alliances and digital transformation (DX).

Furthermore, we established the Management Strategy Committee for the purpose of accelerating the implementation of the initiatives of the Medium-term Management Plan and enhancing their effectiveness, and based on the results of the verification, we have formulated concrete action plans and are steadily advancing initiatives according to our roadmap.

 

Regarding shareholder returns, we aim to exceed ¥80 billion by March 2029. We will enhance shareholder value by continuing to increase dividend stably and executing share buybacks in timely manner.

 

We will continue to meet societal expectations and work diligently to sustainably enhance our corporate value, guided by our medium-term management plan, " Create the Next Generation."　We look forward to your continued support.